thanks for the well researched info skintWell not to detract...

thanks for the well researched info skint
Well not to detract from how thorough your answers were they tend to raise more questions regarding how SBP compares to SPH

ONYX I see only has one drug in development which is the same as SBP but has a market cap around $3.5 Billion while SBP has a sub $12M market cap about 1/300 that of Onyx

why the big difference??? probably stage of development, this seems to be around 6 years behind onyx which had 163 patients in a phase 1 back in 2002

Between 2002 and 2004 Onyx stock rose from $4 to $60 while going through an interum phase 2 trial showing encouraging signs of tumor reduction.

Flip side is the phase 2 results for ONYX could have been poor in which case the stock would still be $4

SO my conclusion is its possible this stock could also go up 1400 % in the next few years or it could go back to 1 cent.